Literature DB >> 8247339

Saireito (a Chinese herbal drug)-stimulated secretion and synthesis of pituitary ACTH are mediated by hypothalamic corticotropin-releasing factor.

Y Nakano1, T Suda, F Tozawa, I Dobashi, Y Sato, N Ohmori, T Sumitomo, H Demura.   

Abstract

Administration of Saireito, a Saiko agent (a Chinese herbal drug), via a stomach cannula stimulates ACTH release and proopiomelanocortin, the precursor for ACTH, gene expression in the rat anterior pituitary. To study whether Saireito-stimulated secretion and synthesis of ACTH are mediated by hypothalamic corticotropin-releasing factor (CRF), we examined the effect of passive immunization of endogenous CRF by i.v. administration of CRF antiserum on Saireito-increased plasma ACTH levels and proopiomelanocortin gene expression in the rat anterior pituitary, under pentobarbital anesthesia. CRF antiserum inhibited Saireito-induced plasma ACTH levels and proopiomelanocortin mRNA levels in the anterior pituitary. This result indicates that Saireito stimulates CRF neurons to increase CRF release, which stimulates secretion and synthesis of ACTH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247339     DOI: 10.1016/0304-3940(93)90921-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  TJS-010, a new prescription of oriental medicine, enhances 8-OH-DPAT-induced effects in rats.

Authors:  A Kagaya; A J Tanra; H Shinno; A Kugaya; M Muraoka; T Oyamada; Y Uchitomi; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Effects of Saireito on the ovarian function of patients with polycystic ovary syndrome.

Authors:  Machi Okamoto; Hideya Sakakibara; Hiroshi Yoshida; Yuka Fukazawa; Kunitomo Takashima; Yoshihito Kondo; Mario Ikeda; Masahiko Ishikawa; Fumiki Hirahara
Journal:  Reprod Med Biol       Date:  2010-06-22

3.  Therapeutic effects of saireito (chai-ling-tang), a traditional Japanese herbal medicine, on lymphedema caused by radiotherapy: a case series study.

Authors:  Aiko Nagai; Yuta Shibamoto; Keiko Ogawa
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.